These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

398 related items for PubMed ID: 3455914

  • 21. Mathematical model of paracrine interactions between osteoclasts and osteoblasts predicts anabolic action of parathyroid hormone on bone.
    Komarova SV.
    Endocrinology; 2005 Aug; 146(8):3589-95. PubMed ID: 15860557
    [Abstract] [Full Text] [Related]

  • 22. Morphology of osteoclasts in resorbing fetal rat bone explants: effects of PTH and AIF in vitro.
    Wezeman FH, Kuettner KE, Horton JE.
    Anat Rec; 1979 Jul; 194(3):311-23. PubMed ID: 224732
    [Abstract] [Full Text] [Related]

  • 23. Effect of pH on bone resorption by rat osteoclasts in vitro.
    Arnett TR, Dempster DW.
    Endocrinology; 1986 Jul; 119(1):119-24. PubMed ID: 3720660
    [Abstract] [Full Text] [Related]

  • 24. Constitutive expression of osteoclast-stimulating activity by normal clonal osteoblast-like cells: effects of parathyroid hormone and 1,25-dihydroxyvitamin D3.
    Collin P, Guenther HL, Fleisch H.
    Endocrinology; 1992 Sep; 131(3):1181-7. PubMed ID: 1505460
    [Abstract] [Full Text] [Related]

  • 25. Additive effects of acidosis and parathyroid hormone on mouse osteoblastic and osteoclastic function.
    Bushinsky DA, Nilsson EL.
    Am J Physiol; 1995 Dec; 269(6 Pt 1):C1364-70. PubMed ID: 8572164
    [Abstract] [Full Text] [Related]

  • 26. Human macrophage colony-stimulating factor inhibits bone resorption by osteoclasts disaggregated from rat bone.
    Hattersley G, Dorey E, Horton MA, Chambers TJ.
    J Cell Physiol; 1988 Oct; 137(1):199-203. PubMed ID: 3262621
    [Abstract] [Full Text] [Related]

  • 27. Osteoblastic control of osteoclast bone resorption in a serum-free co-culture system. Lack of effect of parathyroid hormone.
    Teti A, Grano M, Colucci S, Zambonin Zallone A.
    J Endocrinol Invest; 1992 Oct; 15(9 Suppl 6):63-8. PubMed ID: 1300341
    [No Abstract] [Full Text] [Related]

  • 28. Structural requirements for the action of parathyroid hormone-related protein (PTHrP) on bone resorption by isolated osteoclasts.
    Evely RS, Bonomo A, Schneider HG, Moseley JM, Gallagher J, Martin TJ.
    J Bone Miner Res; 1991 Jan; 6(1):85-93. PubMed ID: 2048435
    [Abstract] [Full Text] [Related]

  • 29. The regulation of osteoclastic development and function.
    Chambers TJ.
    Ciba Found Symp; 1988 Jan; 136():92-107. PubMed ID: 3068019
    [Abstract] [Full Text] [Related]

  • 30. Osteoblasts mediate insulin-like growth factor-I and -II stimulation of osteoclast formation and function.
    Hill PA, Reynolds JJ, Meikle MC.
    Endocrinology; 1995 Jan; 136(1):124-31. PubMed ID: 7828521
    [Abstract] [Full Text] [Related]

  • 31. The effects of parathyroid hormone (PTH) and PTH-related peptide on osteoclast resorption of bone slices in vitro: an analysis of pit size and the resorption focus.
    Murrills RJ, Stein LS, Fey CP, Dempster DW.
    Endocrinology; 1990 Dec; 127(6):2648-53. PubMed ID: 2249618
    [Abstract] [Full Text] [Related]

  • 32. A two-receptor model for the action of parathyroid hormone on osteoblasts: a role for intracellular free calcium and cAMP.
    Löwik CW, van Leeuwen JP, van der Meer JM, van Zeeland JK, Scheven BA, Herrmann-Erlee MP.
    Cell Calcium; 1985 Aug; 6(4):311-26. PubMed ID: 2994886
    [Abstract] [Full Text] [Related]

  • 33. DNA synthesis is not necessary for osteoclastic responses to parathyroid hormone in cultured fetal rat long bones.
    Lorenzo JA, Raisz LG, Hock JM.
    J Clin Invest; 1983 Dec; 72(6):1924-9. PubMed ID: 6643680
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. TRANCE is necessary and sufficient for osteoblast-mediated activation of bone resorption in osteoclasts.
    Fuller K, Wong B, Fox S, Choi Y, Chambers TJ.
    J Exp Med; 1998 Sep 07; 188(5):997-1001. PubMed ID: 9730902
    [Abstract] [Full Text] [Related]

  • 36. Lycopene I--effect on osteoclasts: lycopene inhibits basal and parathyroid hormone-stimulated osteoclast formation and mineral resorption mediated by reactive oxygen species in rat bone marrow cultures.
    Rao LG, Krishnadev N, Banasikowska K, Rao AV.
    J Med Food; 2003 Sep 07; 6(2):69-78. PubMed ID: 12935316
    [Abstract] [Full Text] [Related]

  • 37. Mammalian collagenase predisposes bone surfaces to osteoclastic resorption.
    Chambers TJ, Darby JA, Fuller K.
    Cell Tissue Res; 1985 Sep 07; 241(3):671-5. PubMed ID: 2992797
    [Abstract] [Full Text] [Related]

  • 38. Inhibition of osteoclastic motility by prostaglandins I2, E1, E2 and 6-oxo-E1.
    Chambers TJ, Ali NN.
    J Pathol; 1983 Mar 07; 139(3):383-97. PubMed ID: 6339702
    [Abstract] [Full Text] [Related]

  • 39. Antisense oligodeoxynucleotide evidence that a unique osteoclastic protein-tyrosine phosphatase is essential for osteoclastic resorption.
    Suhr SM, Pamula S, Baylink DJ, Lau KH.
    J Bone Miner Res; 2001 Oct 07; 16(10):1795-803. PubMed ID: 11585343
    [Abstract] [Full Text] [Related]

  • 40. Human parathyroid hormone (PTH)-related protein and human PTH: comparative biological activities on human bone cells and bone resorption.
    Fukayama S, Bosma TJ, Goad DL, Voelkel EF, Tashjian AH.
    Endocrinology; 1988 Dec 07; 123(6):2841-8. PubMed ID: 2848688
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 20.